A
Aisha Miah
Researcher at The Royal Marsden NHS Foundation Trust
Publications - 110
Citations - 4149
Aisha Miah is an academic researcher from The Royal Marsden NHS Foundation Trust. The author has contributed to research in topics: Sarcoma & Soft tissue sarcoma. The author has an hindex of 25, co-authored 97 publications receiving 3102 citations. Previous affiliations of Aisha Miah include Institute of Cancer Research.
Papers
More filters
Journal ArticleDOI
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.
Christopher M. Nutting,Christopher M. Nutting,James P Morden,Kevin J. Harrington,Kevin J. Harrington,Teresa Guerrero Urbano,Shreerang Bhide,Catharine H. Clark,Elizabeth Miles,Aisha Miah,Kate Newbold,Mary Anne Lagmay Tanay,Fawzi Adab,Sarah Jefferies,Christopher D Scrase,Beng K. Yap,Roger A'Hern,M. Sydenham,M. Emson,Emma Hall +19 more
TL;DR: Sparing the parotid glands with IMRT significantly reduces the incidence of xerostomia and leads to recovery of saliva secretion and improvements in associated quality of life, and thus strongly supports a role for IMRT in squamous-cell carcinoma of the head and neck.
Journal ArticleDOI
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial.
Sylvie Bonvalot,Alessandro Gronchi,Cécile Le Péchoux,Carol Jane Swallow,Dirk C. Strauss,Pierre Meeus,Frits van Coevorden,Stephan Stoldt,Eberhard Stoeckle,Piotr Rutkowski,Marco Rastrelli,Chandrajit P. Raut,Chandrajit P. Raut,Daphne Hompes,Antonino De Paoli,Claudia Sangalli,Charles Honoré,Peter Chung,Aisha Miah,Jean-Yves Blay,Marco Fiore,Jean Jacques Stelmes,Angelo Paolo Dei Tos,Elizabeth H. Baldini,Elizabeth H. Baldini,Saskia Litière,Sandrine Marreaud,Hans Gelderblom,Rick L. Haas +28 more
TL;DR: Preoperative radiotherapy should not be considered as standard of care treatment for retroperitoneal sarcoma, and the primary endpoint was abdominal recurrence-free survival.
Journal ArticleDOI
Systemic treatment of soft-tissue sarcoma-gold standard and novel therapies.
TL;DR: This Review aims to describe the current gold standard treatment for specific STS subtypes as well as outline future promising therapies in the pipeline.
Journal ArticleDOI
Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma
Christopher M. Nutting,C.M.L. van Herpen,Aisha Miah,S.A. Bhide,Jean-Pascal Machiels,Jan Buter,Charles Kelly,D. de Raucourt,Kevin J. Harrington +8 more
TL;DR: 3-AP Triapine as a single agent, at this dose and schedule, is well tolerated but has only minor activity in the treatment of advanced HNSCC.
Journal ArticleDOI
Desmoid-type fibromatosis
Sofia Otero,Eleanor Moskovic,Dirk C. Strauss,Charlotte Benson,Aisha Miah,Khin Thway,Christina Messiou +6 more
TL;DR: The typical imaging characteristics of desmoid-type fibromatosis are discussed and diagnostic and follow-up magnetic resonance imaging protocols are suggested, with details of suitable sequences and scanning intervals.